Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

novartissunlight_copy

Novartis’s secukinumab meets Phase 3 goals

October 1, 2015 Research and Development Novartis, Secukinumab, arthritis

Novartis has announced that its secukinumab medication for treatment of psoriatic arthritis (PsA), met its primary endpoint in the pivotal …
News
sayana_press_and_pack

Pfizer’s self-injectable contraceptive becomes UK’s first

September 30, 2015 Medical Communications, Research and Development, Sales and Marketing Pfizer, Syayana Press

Pfizer’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the UK for administration by self-injection following …
News
novartis

Study shows Novartis’s Afinitor positively reduces tumors

September 30, 2015 Research and Development Afinitor, Novartis

Novartis has announced the results of a Phase III pivotal study, showing Afinitor (everolimus) tablets reduced the risk of progression …
News

Genentech’s ocrelizumab shows efficacy in phase III trial

September 30, 2015 Research and Development Genentech, MS, Roche, ocrelizumab

Roche subsidiary Genentech has announced positive results from a pivotal phase III study of its investigational medicine ocrelizumab in people …
News
heptares_logo

Heptares awarded $5.5 million grant to combat cocaine addiction

September 30, 2015 Research and Development Heptares

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, has been awarded a grant from the National Institute …
News

Roche says Esbriet shown to extend lives of IPF patients

September 30, 2015 Medical Communications, Research and Development, Sales and Marketing Esbriet, Roche, idiopathic pulmonary fibrosis

Roche has presented new clinical data and abstracts on Esbriet (pirfenidone) in the treatment of idiopathic pulmonary fibrosis (IPF), showing …
News
asthma inhalers

New study reveals true impact of severe asthma in Europe

September 29, 2015 Research and Development ERS2015, asthma

The results of a new, comprehensive survey have revealed the true burden of severe asthma faced by patients across Europe. …
News
Opdivo

Bristol-Myers Squibb notches kidney cancer first with Opdivo

September 28, 2015 Research and Development Afinitor, Bristol-Myers Squibb, Kidney cancer, advanced kidney cancer, everolimus, nivolumab, opdivo, renal cell carcinoma

Bristol-Myers Squibb has announced positive results from a Phase III study comparing Opdivo to Afinitor, the Novartis treatment that is …
News
glioblastoma

ImmunoCellular awarded $19.9 million grant for ICT-107 phase 3 trial for glioblastoma

September 25, 2015 Research and Development California Institute for Regenerative Medicine, Cancer, ICT-107, brain cancer, glioblastoma

ImmunoCellular Therapeutics has been awarded a $19.9 million grant by California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, …
News

Novartis’ new heart failure medicine recommended for EU approval

September 25, 2015 Medical Communications, Research and Development Entresto, Novartis, eams, heart failure

The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Novartis’s heart failure medication Entresto …
News
velocity_health

Merck and Wayra to tackle NHS funding gap with startup rewards programme

September 25, 2015 Research and Development MSD, Merck

Merck Sharpe and Dohme (MSD) and Wayra Open Future, Telefonica’s digital start up accelerator, are investing in digital innovation in …
News
copd

Genetic study reveals new associations with lung disease and smoking behaviour

September 25, 2015 Medical Communications, Research and Development COPD, lung cancer, smkoing

New research published in The Lancet Respiratory Medicine and presented at this year’s European Respiratory Society (ERS) Congress in Amsterdam …
News
BI building

Boehringer and BioMed X crowdsource top scientists to fight COPD

September 23, 2015 Research and Development Boehringer Ingelheim, COPD

Boehringer Ingelheim and BioMed X have used a crowdsourcing strategy to establish a global research team to collaborate on the …
News
HIV infected cell

ViiV in late-stage HIV trial success

September 23, 2015 Research and Development HIV, Triumeq, ViiV, virology

Switching patients to Triumeq, a once-daily combination treatment for HIV, is as effective as remaining on antiretroviral therapy in certain …
News

Pharma ‘is getting better at drug R&D’

September 23, 2015 Research and Development R&D, drug development, market access, productivity

An investigation into pharma R&D data shows that drugmakers are becoming more successful at identifying the right candidates for drug …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026